mRNA delivery through fibronectin associated liposome-apatite particles: a new approach for enhanced mRNA transfection to mammalian cell.
暂无分享,去创建一个
[1] N. Bavarsad,et al. mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[2] J. Hecker,et al. Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells. , 2010, International journal of pharmaceutics.
[3] F. Zohra,et al. High performance mRNA transfection through carbonate apatite-cationic liposome conjugates. , 2009, Biomaterials.
[4] H. Rammensee,et al. Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients , 2009, Journal of immunotherapy.
[5] F. Zohra,et al. Effective delivery with enhanced translational activity synergistically accelerates mRNA-based transfection. , 2007, Biochemical and biophysical research communications.
[6] W. Ge,et al. Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo. , 2007, Hepato-gastroenterology.
[7] G. Gaudernack,et al. Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells , 2006, Cancer Immunology, Immunotherapy.
[8] Wen-Chao Liu,et al. Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells. , 2006, Cellular immunology.
[9] F. Zohra,et al. Drastic effect of nanoapatite particles on liposome-mediated mRNA delivery to mammalian cells. , 2005, Analytical biochemistry.
[10] F. Zohra,et al. Integrin-supported fast rate intracellular delivery of plasmid DNA by extracellular matrix protein embedded calcium phosphate complexes. , 2005, Biochemistry.
[11] S. Aamdal,et al. Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination , 2005, Cancer Gene Therapy.
[12] V. Vogel,et al. Fibronectin conformational changes induced by adsorption to liposomes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[13] Andrés J. García,et al. α2β1 integrin‐specific collagen‐mimetic surfaces supporting osteoblastic differentiation , 2004 .
[14] W. Driessen,et al. Peptide-mediated Gene Transfer of Cationic Lipid/Plasmid DNA Complexes to Endothelial Cells , 2004, Journal of drug targeting.
[15] Chi-Hung Lin,et al. Studies on the microspheres comprised of reconstituted collagen and hydroxyapatite. , 2004, Biomaterials.
[16] R. Schiffelers,et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. , 2004, Nucleic acids research.
[17] T. Kissel,et al. Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer , 2003, The journal of gene medicine.
[18] D. Willis,et al. Formation of LID vector complexes in water alters physicochemical properties and enhances pulmonary gene expression in vivo , 2003, Gene Therapy.
[19] J. Hecker,et al. Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: methods and evidence for nonviral mRNA gene delivery to the central nervous system. , 2003, Human gene therapy.
[20] Y. Shinohara,et al. Lipoplex size determines lipofection efficiency with or without serum , 2003, Molecular membrane biology.
[21] P. Harvie,et al. Targeting of Lipid-Protamine-DNA (LPD) Lipopolyplexes Using RGD Motifs , 2003, Journal of liposome research.
[22] M. Ogris,et al. Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells. , 2001, Nucleic acids research.
[23] J. Hecker,et al. Nonviral gene delivery to the lateral ventricles in rat brain: initial evidence for widespread distribution and expression in the central nervous system. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[24] S. Nair,et al. RNA transfected dendritic cells as cancer vaccines. , 2000, Current opinion in molecular therapeutics.
[25] Seng H. Cheng,et al. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[26] M. Cotten,et al. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus , 2000, Gene Therapy.
[27] K. Karikó,et al. Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA , 1999, Gene Therapy.
[28] M. Goligorsky,et al. RGD‐recognizing integrins mediate interactions of human prostate carcinoma cells with endothelial cells in vitro , 1999, The Prostate.
[29] M. Stedman,et al. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. , 1999, Human gene therapy.
[30] D. Escande,et al. Polyethylenimine but Not Cationic Lipids Promotes Transgene Delivery to the Nucleus in Mammalian Cells* , 1998, The Journal of Biological Chemistry.
[31] R. Levinsky,et al. Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. , 1998, Human gene therapy.
[32] D. Scherman,et al. Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. , 1998, Biochimica et biophysica acta.
[33] M. Somerman,et al. Expression of Adhesion Molecules during Tooth Resorption in Feline Teeth: A Model System for Aggressive Osteoclastic Activity , 1996, Journal of dental research.
[34] R. Klebe,et al. Comments on the Clinical Application of Fibronectin in Dentistry , 1988, Journal of dental research.
[35] K. Takita,et al. Immunofluorescence localization of type I and type III collagen and fibronectin in mouse dental tissues in late development and during molar eruption. , 1987, Archives of oral biology.